Skip to main content
. 2020 Aug 29;222(10):1629–1634. doi: 10.1093/infdis/jiaa531

Table 1.

Characteristics of Patients Whose Specimens Were Tested

Specimen IDa SARS-CoV-2 PCR Result Type of Specimen Symptoms Suggestive of COVID-19 Days After Symptom Onset and Serum Collection COVID-19 Severity
P1a Positive Serum Yes 8 Severe
P1b Positive Serum Yes 11 Severe
P1c Positive Serum Yes 15 Severe
P2a Positive Serum Yes 7 Severe
P2b Positive Serum Yes 10 Severe
P3 Positive Serum Yes 22 Mild
P4 Inconclusive Serum Yes 21 Mild
P5b Positive Serum Unknown Unknown Unknown
P6b Positive Serum Unknown Unknown Unknown
P7b Positive Serum Unknown Unknown Unknown
P8b Positive Serum Unknown Unknown Unknown
TF1–TF14 Positive Plasma Unknown Unknown Unknown
Convalescent plasma pool Positive Plasma Unknown Unknown Unknown
N1 NA; collected Oct 2019 Plasma NA NA NA
N2 NA; collected Nov 2019 Plasma NA NA NA
N3 NA; collected Oct 2019 Plasma NA NA NA
N4–N13c Unknown Plasma NA NA NA
Nonconvalescent plasma poolc Unknown Plasma NA NA NA

Abbreviations: COVID-19, coronavirus disease 2019; NA, not applicable or not available; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

aSpecimens from P: sera of patients infected with SARS-CoV-2; N: normal, uninfected individual; TF: citrated plasma from units to be used for transfusion.

bP5–P8 were de-identified.

cN4–N13 were derived from the general blood bank plasma inventory.